What Makes Blood Cell Transfection So Challenging?
Transfecting blood-derived cells—particularly leukemia and lymphoma cell lines—poses a unique set of challenges for researchers. Unlike adherent cells such as fibroblasts or epithelial lines, blood cells grow in suspension, lack strong cell–cell contact, and have distinct membrane properties that make them resistant to conventional transfection techniques like lipofection or calcium phosphate precipitation.
Their high proliferation rate and immunologic origin also mean that these cells may activate strong stress responses or apoptosis pathways when exposed to foreign genetic material. This limits transfection efficiency and increases cytotoxicity, particularly when introducing large plasmids or high concentrations of siRNA.
Electroporation has emerged as the most effective method for these cell types, allowing brief permeabilization of the cell membrane using electrical pulses. However, even electroporation requires careful optimization of buffer composition, voltage parameters, and cell density to achieve high viability and transgene expression. Using cell-type–specific kits and validated protocols can significantly increase success rates when working with blood cancer models.
References: Altogen.com Altogenlabs.com